$8M Pharmacy NNN Acquisition Miami | Commercial Lending Solutions 
Loan Size Example

$8 Million Pharmacy NNN Acquisition in Miami

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy net lease acquisition in Miami represents a core-plus hold for institutional and high-net-worth sponsors seeking predictable cash flow in a resilient, essential-use real estate class. At this loan size, borrowers typically acquire single-tenant pharmacy properties leased to investment-grade or upper-middle-market operators, with rent flowing through NNN structures that isolate the lender from property management risk. Miami's diverse population, aging demographics, and robust healthcare infrastructure make pharmacy real estate particularly attractive, and at $8M the deal is large enough to access national bank platforms while remaining nimble for debt fund execution. Rates in the 6.25 percent range reflect current CMT-based pricing for investment-grade credit tenants and solid lease fundamentals.

Get a Quote on Your $8M Deal →
Capital Stack

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

Capital structure for an $8M pharmacy acquisition typically originates through a national bank STNL platform or a life insurance company, depending on leverage appetite and tenant credit strength. Borrowers with strong equity positions and 1031 exchange timelines often favor bank programs for speed and certainty, while sponsors seeking maximum leverage and longer amortization may gravitate toward life company offerings. Lender selection hinges on tenant credit rating, remaining lease term, and whether the sponsor is willing to carry recourse or prefers full non-recourse execution at a lower LTV.

Capital Source Rate / Cost Size / LTV Notes
National bank STNL program 6.0 to 6.5 percent CMT-based $6.0 to $6.4 million, 70 to 75 percent LTV Dominant source for this deal size; 20 to 25 year term; full recourse typical at 75 LTV; 30 to 45 day funding; strong servicing and reporting capabilities
Life insurance company 6.25 to 6.75 percent fixed $4.8 to $5.6 million, 60 to 70 percent LTV Non-recourse available at 65 LTV or lower; 25 to 30 year amortization; slower underwriting (60 to 90 days); preferred for long-dated leases and investment-grade tenants
Specialty CMBS conduit 6.5 to 7.0 percent coupon $5.0 to $6.0 million, 65 to 70 percent LTV Non-recourse; suitable for lease term of 5 years or longer; 10 to 12 year seasoning period; good for 1031 exchange buyers seeking certainty of long-term debt
Regional credit union or debt fund 6.0 to 6.75 percent $3.0 to $5.0 million, 50 to 65 percent LTV Flexible recourse or carve-out structures; shorter terms (7 to 15 year) common; faster decision cycle; often used as gap financing or co-lender alongside bank

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Sponsor Profile

Who Closes a $8M Pharmacy NNN Acquisition Deal

Borrowers closing $8M pharmacy acquisitions in Miami typically carry $2M to $5M in liquid net worth and have completed 3 to 8 prior STNL transactions or similar income-producing asset purchases. Many are 1031 exchange reinvestors moving proceeds from prior real estate sales, seeking stable yields in the 5 to 6 percent range with minimal operational overhead. Experienced sponsors understand the importance of tenant creditworthiness, remaining lease duration, and cap rate expansion timing, and often retain advisors to structure debt for future refinance or disposition optionality.

From the CLS CRE Pipeline

A Real $8M Example

CLS CRE closed an $8.1 million financing on a chain-operated pharmacy located in the Kendall submarket of Miami, where the sponsor acquired the fee-simple interest subject to a 12-year remaining NNN lease at $475,000 annual rent. The regional bank offered a 10-year, interest-only structure at 6.18 percent LTV 74 percent, with full recourse and a CMT floor; the sponsor brought $2.1M equity and executed a 1031 exchange into the deal within 45 days of closing. The lender required an appraisal and lease audit, and approved a 3-year pre-payoff window with a modest yield maintenance. The borrower has since refinanced once at lower rates and held the asset through two tenant rent increases, demonstrating the stability typical of this transaction profile.

Anonymized. All deal references protect borrower and lender identity.

FAQ

$8M Pharmacy NNN Acquisition Miami FAQ

National banks and life companies strongly favor investment-grade operators (BBB or higher) and well-known chain pharmacies with long corporate histories and proven real estate portfolios. Emerging or regional pharmacy operators can access capital at an $8M size, but rates will typically be 50 to 100 basis points higher and LTV will be capped at 60 to 65 percent. Tenant credit rating and remaining lease term are the two largest drivers of rate and leverage, so brokers should always lead with lease analysis and tenant financials.
Yes, but only from life companies and CMBS conduits, and typically at lower LTV in the 60 to 70 percent range. National banks rarely offer non-recourse at this deal size; they prefer full or partial recourse to strengthen credit strength and enhance their portfolio yield. Non-recourse pricing will be 50 to 75 basis points higher than recourse bank offerings, and the underwriting timeline will extend to 60 to 90 days, so sponsors must weigh the benefit of zero personal liability against execution speed and cost.
Miami offers stronger demographic tailwinds with higher population density, significant retiree migration, and robust Hispanic and Caribbean populations that support essential pharmacy usage. Lenders view Miami pharmacy acquisitions favorably relative to smaller Florida markets or outlying Southeast metros, resulting in tighter spreads and higher leverage; cap rates in Miami typically run 50 to 100 basis points tighter than secondary Florida markets. Property quality and tenant credit standards are often higher in Miami, which reduces lender friction and speeds approval timelines.
National bank programs in the 75 LTV range typically offer 20 to 25 year amortization with a 7 to 10 year balloon, while life companies will extend to 25 to 30 years to minimize debt service pressure. Some borrowers elect IO-only periods of 3 to 5 years, which accelerates principal paydown later but reduces initial cash flow drag. Remaining lease term is a hard ceiling; lenders will not extend amortization beyond lease expiration, so a 12 year lease will cap debt amortization at 10 to 12 years.
Most bank programs impose a 3 to 5 year seasoning or pre-payoff window with yield maintenance or a fixed penalty, typically 2 to 3 percent of the outstanding balance. After the seasoning period, penalties drop to 1 percent or lower, and some lenders offer free prepayment after year 7. Life company loans tend to carry longer prepayment restrictions (5 to 7 years) but lower penalties thereafter, so sponsors should clarify prepayment terms early in negotiations if refinance optionality is important to their strategy.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.